Early Neurocognitive Rehabilitation in Intensive Care (ENRIC)

March 8, 2022 updated by: Lluis Blanch, Corporacion Parc Tauli

The purpose of this project is to assess the efficacy of an early neurocognitive intervention for ICU patients, in terms of psychopathological, neuropsychological and functional improvement. The treatment is supported in an interactive advanced computing platform that includes the continuous biomedical registration of the patients and a virtual reality software specifically designed for critical patients.

The investigators expect an improvement in neuropsychological, psychopathological and functional status at hospital discharge and 3 months follow-up in those patients that have received the early neurocognitive intervention comparing with patients treated as usual. Furthermore the investigators expect a decrease of episodes and/or duration of delirium in ICU patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Sabadell, Barcelona, Spain, 08208
        • Corporació Parc Tauli

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged between 18 and 80 years
  • Patients receiving mechanical ventilation for at least 24 hours
  • Patients scoring more than 8 on the Glasgow Coma Scale (GCS) and more than 2 on the Sedation Agitation Scale (SAS)
  • Patients haemodynamically stable
  • Informed consent signed by the closest relatives.

Exclusion Criteria:

  • Patients with previous neurologic pathology or focal brain injury before ICU admission
  • Patients with serious psychiatric pathology (major depression, psychosis, bipolar disease) or mentally retarded
  • Patients with sensorial alterations needed to interact with the neurocognitive stimulation programme
  • patients whose closest relatives refuse the subject to be included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Treatment as usual
Experimental: Neurocognitive stimulation
Intervention of experimental group consists in a neurocognitive stimulation treatment. Using kinect technology, patient can interact with a virtual environment where different cognitive tasks have to be resolved.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attention
Time Frame: Hospital discharge and 3-months after hospital discharge
  • Verbal attention: Digits Forward subtest of the WAIS III (Wechsler, 1999)
  • Visual attention: Spatial Localization Forward subtest of the WMS III (Wechsler, 1999)
  • Sustained/Selective attention: Continuous Performance Test (Conners, 1992)
Hospital discharge and 3-months after hospital discharge
Memory
Time Frame: Hospital discharge and 3-months after hospital disharge
  • Verbal learning and memory: Auditory Verbal Learning Test (Rey, 1964)
  • Visual learning and memory: 10/36 Spatial Recall Test (Rao, 1992)
  • Visual recognition: Benton Visual Retention Test (Benton, 1983)
Hospital discharge and 3-months after hospital disharge
Executive Functions
Time Frame: Hospital discharge and 3-months after hospital discharge
  • Stimuli alternation and sequencing: Trail Making Test A-B (Mimeo & Manga, 1999)
  • Automatic inhibition response: Stroop Test (Golden & Charles, 1978)
  • Visual planning: Tower of London (Shallice, 1982).
  • Phonetic verbal fluency: FAS test (Spreen and Benton, 1995)
  • Semantic verbal fluency: Animals 1' (Benton & Hamsher, 1976)
Hospital discharge and 3-months after hospital discharge
Speed processing
Time Frame: Hospital discharge and 3-months after hospital discharge
- Information processing speed: Symbol Search subtest of the WAIS III (Wechsler, 1999)
Hospital discharge and 3-months after hospital discharge
Psychopathological status
Time Frame: Hospital discharge and 3-monts after hospital discharge
  • Depression: Hamilton Depression Rating Scale (HDRS) (Hamilton, 1960)
  • Anxiety: Hamilton Anxiety Rating Scale (HAM-A) (Hamilton, 1959)
Hospital discharge and 3-monts after hospital discharge
Functional Status
Time Frame: hospital discharge and 3-months after hospital discharge
  • Quality of life questionnaire: Satisfaction and Pleasure (Q-LES-Q) (Endicott, J., Nee, J., Harrison, W. & Blumenthal, R., 1993)
  • Lawton and Brody Functional Scale (1969)
hospital discharge and 3-months after hospital discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delirium
Time Frame: Every day during ICU stay
Number of episodes and duration of delirium: Confusional Assessment Method for Intensive Care Unit (CAM-ICU)
Every day during ICU stay

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lluis Blanch, Phd, Fundacio Parc Tauli
  • Study Director: Antoni Artigas, Phd, Corporació Parc Taulí- Critical Care Unit chair

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2015

Primary Completion (Actual)

July 1, 2020

Study Completion (Actual)

September 1, 2020

Study Registration Dates

First Submitted

February 28, 2014

First Submitted That Met QC Criteria

March 3, 2014

First Posted (Estimate)

March 5, 2014

Study Record Updates

Last Update Posted (Actual)

March 9, 2022

Last Update Submitted That Met QC Criteria

March 8, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on Neurocognitive stimulation

Subscribe